These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25951239)

  • 41. The Causes and Outcomes of Early Relaparotomy Following Pediatric Living Donor Liver Transplantation.
    Okada N; Sanada Y; Onishi Y; Urahashi T; Ihara Y; Yamada N; Hirata Y; Katano T; Imai T; Ushijima K; Ogaki K; Otomo S; Mizuta K
    Liver Transpl; 2019 Jul; 25(7):1066-1073. PubMed ID: 30865366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pediatric liver retransplantation from living donors can be considered as a therapeutic option for patients with irreversible living donor graft failure.
    Urahashi T; Mizuta K; Sanada Y; Wakiya T; Umehara M; Hishikawa S; Hyodo M; Sakuma Y; Fujiwara T; Yasuda Y; Kawarasaki H
    Pediatr Transplant; 2011 Dec; 15(8):798-803. PubMed ID: 21923885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. More than a quarter of a century of liver transplantation in Kaohsiung Chang Gung Memorial Hospital.
    Chen CL; Concejero AM; Cheng YF
    Clin Transpl; 2011; ():213-21. PubMed ID: 22755415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Living Donor Liver Transplantation in Children: Perioperative Risk Factors and a Nomogram for Prediction of Survival.
    Lu YG; Pan ZY; Zhang S; Lu YF; Zhang W; Wang L; Meng XY; Yu WF
    Transplantation; 2020 Aug; 104(8):1619-1626. PubMed ID: 32732839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience.
    Kamath BM; Yin W; Miller H; Anand R; Rand EB; Alonso E; Bucuvalas J;
    Liver Transpl; 2012 Aug; 18(8):940-8. PubMed ID: 22454296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome of living donor liver transplantation for post-Kasai biliary atresia in adults.
    Kyoden Y; Tamura S; Sugawara Y; Yamashiki N; Matsui Y; Togashi J; Kaneko J; Kokudo N; Makuuchi M
    Liver Transpl; 2008 Feb; 14(2):186-92. PubMed ID: 18236393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Living Donor Liver Transplantation in Patients 70 Years or Older.
    Oezcelik A; Dayangac M; Guler N; Yaprak O; Erdogan Y; Akyildiz M; Sevdik Z; Yuzer Y; Tokat Y
    Transplantation; 2015 Jul; 99(7):1436-40. PubMed ID: 25606791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunologic benefit of maternal donors in pediatric living donor liver transplantation.
    Kim MH; Akbari O; Genyk Y; Kohli R; Emamaullee J
    Pediatr Transplant; 2019 Nov; 23(7):e13560. PubMed ID: 31402535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Living donor liver transplantation in maple syrup urine disease - Case series and world's youngest domino liver donor and recipient.
    Mohan N; Karkra S; Rastogi A; Vohra V; Soin AS
    Pediatr Transplant; 2016 May; 20(3):395-400. PubMed ID: 26869348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network.
    Smith CM; Davies DB; McBride MA
    Clin Transpl; 2000; ():19-30. PubMed ID: 11512312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duct-to-duct biliary reconstruction without a stent in pediatric living-donor liver transplantation.
    Haberal M; Karakayali H; Atiq A; Sevmis S; Moray G; Ozcay F; Boyvat F
    Transplant Proc; 2011 Mar; 43(2):595-7. PubMed ID: 21440772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth curves of pediatric patients with biliary atresia following living donor liver transplantation: factors that influence post-transplantation growth.
    Saito T; Mizuta K; Hishikawa S; Kawano Y; Sanada Y; Fujiwara T; Yasuda Y; Sugimoto K; Sakamoto K; Kawarasaki H
    Pediatr Transplant; 2007 Nov; 11(7):764-70. PubMed ID: 17910654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients.
    Diem HV; Evrard V; Vinh HT; Sokal EM; Janssen M; Otte JB; Reding R
    Transplantation; 2003 May; 75(10):1692-7. PubMed ID: 12777858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver transplantation for children with biliary atresia in the pediatric end-stage liver disease era: the role of insurance status.
    Arnon R; Annunziato RA; Willis A; Parbhakar M; Chu J; Kerkar N; Shneider BL
    Liver Transpl; 2013 May; 19(5):543-50. PubMed ID: 23447504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Living-donor liver transplantation for congenital biliary atresia with porto-pulmonary hypertension and moderate or severe pulmonary arterial hypertension: Kyoto University experience.
    Ogawa E; Hori T; Doi H; Segawa H; Uemoto S
    Clin Transplant; 2014 Sep; 28(9):1031-40. PubMed ID: 24986560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Split-liver transplantation eliminates the need for living-donor liver transplantation in children with end-stage cholestatic liver disease.
    Gridelli B; Spada M; Petz W; Bertani A; Lucianetti A; Colledan M; Altobelli M; Alberti D; Guizzetti M; Riva S; Melzi ML; Stroppa P; Torre G
    Transplantation; 2003 Apr; 75(8):1197-203. PubMed ID: 12717203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pretransplant levels of endotoxin can predict the risk of bacterial infections and graft liver function after liver transplantation.
    Sanada Y; Urahashi T; Ihara Y; Okada N; Yamada N; Hirata Y; Mizuta K
    Eur J Pediatr Surg; 2015 Jun; 25(3):236-41. PubMed ID: 24683105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Living donor liver transplantation with body-weight more or less than 10 kilograms.
    Yang SC; Huang CJ; Chen CL; Wang CH; Wu SC; Shih TH; Juang SE; Lee YE; Jawan B; Cheng YF; Cheng KW
    World J Gastroenterol; 2015 Jun; 21(23):7248-53. PubMed ID: 26109812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.
    Kałwak K; Porwolik J; Mielcarek M; Gorczyńska E; Owoc-Lempach J; Ussowicz M; Dyla A; Musiał J; Paździor D; Turkiewicz D; Chybicka A
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1388-401. PubMed ID: 20382248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.